Advanced skills in care innovations for life
We make injectable products better
ASCIL Biopharm is a Drug Delivery Systems (DDS) company focused on research and development of formulations and medical devices with innovative solutions to enhance efficacy, safety and patient outcomes.
Expertise
Controlled Release Formulations
for systemic delivery. High dose & high concentration.
for systemic delivery. High dose & high concentration.
Controlled Release Formulations
for locoregional delivery. Small dose & high concentration.
for locoregional delivery. Small dose & high concentration.
Precision Medical Devices
for liquid, viscous and solid injectables.
for liquid, viscous and solid injectables.
Portfolio
Controlled Release Formulations
APOC | AQUE
Systemic Somatostatin Analogs, novel composition with improved bioavailability and treatment efficacy of neuroendocrine tumors and acromegaly.
OnyMed
Locoregional Antifungals, innovative implants for treatment of nail diseases. An unmet medical need.
Precision Medical Devices
PlaiSir
Control Injectors using rotation to avoid injection force, control the delivery and enhance stability regardless of the viscosity.
SelFill
Micro Dispensers for painless injections using low volumes of liquid or viscous products with dose accuracy and precise target location.
DuoLapse
Combo Connectors, first devices to inject two or more products sequentially in a single shot without mixing.
Partnering
Licensing
Transfer Drug Delivery innovation Systems with proof-of-concept and intellectual property.
Co development
Collaborations to accelerate development of DDSs for new or existing products.
Expert DDS service
Offer advanced services to support partners on their drug delivery systems needs.
If you are interested in partnering with ASCIL, contact us to: busdev@ascil-biopharm.com
Anterior
Siguiente
Contact
Parc Tecnològic del Vallès
Av. Universitat Autonoma 1
08290 Cerdanyola del Valles
Barcelona, Spain
info@ascil-biopharm.com
We are settled in a 1500 m2 building fully equipped for pharmaceutical development. A GMP facility which includes laboratories and a pilot plant for technical and clinical batches (parenteral products).
Dispositiu mèdic
Resolució EMC/1845/2016 d’11 de juliol (DOGC núm. 7172 de 28.7.2106) de convocatòria de la línia d’ajuts a NUCLIS DE RECERCA INDUSTRIAL I DESENVOLUPAMENT EXPERIMENTAL, enregistrada amb el número d’expedient RD16-1-0030 que s’atorga al projecte DISPOSITIU MÈDIC BIODEGRADABLE COM A EINA DE MILLORA TERAPÈUTICA EN MALALTIA DE LLARGA DURADA. Aquest projecte ha estat cofinançat per la Unió Europea a través del Fons Europeu de Desenvolupament Regional (FEDER). Amb la col·laboració d’ACCIÓ.
Medical Device
Resolution EMC/1845/2016 dated 11th of July (DOGC number 7172 de 28.7.2106) regarding the call for aids in NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT registered with the expedient number RD16-1-0030 to grant the project BIODEGRADABLE MEDICAL DEVICE AS A TOOL FOR THERAPEUTIC IMPROVEMENT IN A LONG-TERM ILLNESS. This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIO.
© 2020 ASCIL BIOPHARM | www.ascil-biopharm.com